Mavrilimumab
Encyclopedia
Mavrilimumab is a human monoclonal antibody designed for the treatment of rheumatoid arthritis
.
Mavrilimumab was developed by MedImmune
, Inc.
Rheumatoid arthritis
Rheumatoid arthritis is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks synovial joints. The process produces an inflammatory response of the synovium secondary to hyperplasia of synovial cells, excess synovial fluid, and the development...
.
Mavrilimumab was developed by MedImmune
MedImmune
MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise...
, Inc.